Insiders

04-17 Christer Nordstedt Declines Re-Election as Board Member of IRLAB Therapeutics AB CI
21/08/25 Irlab Therapeutics' New Interim CFO to Start in September MT
21/08/25 IRLAB appoints Roy Jonebrant as interim CFO RE
11/08/25 Irlab CFO Viktor Siewertz leaves the company RE
27/05/24 Sweden’s IRLAB Therapeutics Names New CEO MT
27/05/24 IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024 CI
07/11/23 IRLAB Therapeutics AB Announces Appointment to its Nomination Committee CI
20/06/23 IRLAB Therapeutics AB Elects Christer Nordstedt, Daniel Johnsson and Veronica Wallin as Board Members CI
21/02/23 IRLAB Therapeutics AB Announces the Resignation of An Van Es-Johansson as Board Member CI
20/02/23 Irlab Therapeutics AB Announces Board Changes CI
20/02/23 Irlab Therapeutics AB Announces CEO Changes CI
15/11/22 IRLAB Therapeutics AB Appoints Nomination Committee Ahead of Annual General Meeting 2023 CI
09/06/22 IRLAB Therapeutics AB Appoints Richard Godfrey as CEO, Effective from 1 July 2022 CI
11/05/22 IRLAB Therapeutics AB Approves Board Appointments CI
31/12/21 IRLAB Therapeutics AB Announces Board Changes CI
06/05/21 IRLAB Therapeutics AB Appoints Martin Nicklasson as New Director CI
30/10/20 IRLAB Therapeutics AB Announces Appointments of Members of Nomination Committee CI
06/05/20 IRLAB Therapeutics AB Announces No Dividend Payment for the Previous Financial Year; Elects Gunnar Olsson as New Chairman of the Board CI
17/10/19 IRLAB Therapeutics AB Announces the Appointments to the Nomination Committee CI
25/04/19 IRLAB Therapeutics AB Appoints Carola Lemne as Board Member and New Deputy Chairman of the Board CI
20/09/18 IRLAB Therapeutics AB Announces Nomination Committee Appointments CI
16/05/18 IRLAB Therapeutics AB Announces Board Changes CI
20/09/17 IRLAB Therapeutics AB Announces Executive Nominees CI
No results for this search